These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15012850)

  • 1. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus.
    Martin EM; Novak RM; Fendrich M; Vassileva J; Gonzalez R; Grbesic S; Nunnally G; Sworowski L
    J Int Neuropsychol Soc; 2004 Mar; 10(2):298-300. PubMed ID: 15012850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methodological problems in the evaluation of cognitive disorders associated with HIV].
    Pereda M; Gómez del Barrio A; Ayuso Mateos JL
    Neurologia; 1999 Nov; 14(9):452-8. PubMed ID: 10613019
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurocognitive effects of HIV, hepatitis C, and substance use history.
    Devlin KN; Gongvatana A; Clark US; Chasman JD; Westbrook ML; Tashima KT; Navia B; Cohen RA
    J Int Neuropsychol Soc; 2012 Jan; 18(1):68-78. PubMed ID: 22132928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.
    Bornstein RA; Fama R; Rosenberger P; Whitacre CC; Para MF; Nasrallah HA; Fass RJ
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):254-9. PubMed ID: 8369633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological evaluation of neurologically asymptomatic HIV-infected children.
    Bisiacchi PS; Suppiej A; Laverda A
    Brain Cogn; 2000; 43(1-3):49-52. PubMed ID: 10857661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between employment and neuropsychological impairment in HIV infection.
    van Gorp WG; Baerwald JP; Ferrando SJ; McElhiney MC; Rabkin JG
    J Int Neuropsychol Soc; 1999 Sep; 5(6):534-9. PubMed ID: 10561934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.
    Rippeth JD; Heaton RK; Carey CL; Marcotte TD; Moore DJ; Gonzalez R; Wolfson T; Grant I;
    J Int Neuropsychol Soc; 2004 Jan; 10(1):1-14. PubMed ID: 14751002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of HIV-related neuropsychological impairment: a review of methodological aspects].
    RodríIguez Alvarez M; Rodriguez Salgado D
    Actas Esp Psiquiatr; 2003; 31(2):79-84. PubMed ID: 12677472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
    Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
    Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized and traditional stroop task dysfunction in HIV-1 infection.
    Hinkin CH; Castellon SA; Hardy DJ; Granholm E; Siegle G
    Neuropsychology; 1999 Apr; 13(2):306-16. PubMed ID: 10353380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in HIV-1-infected drug abusers.
    Grassi MP; Perin C; Clerici F; Zocchetti C; Cargnel A; Mangoni A
    Acta Neurol Scand; 1993 Aug; 88(2):119-22. PubMed ID: 8213055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse.
    Lopez SJ; Ryan JJ; Sumerall SW; Lichtenberg JW; Glasnapp D; Krieshok TS; Van Fleet JN
    Psychol Rep; 2001 Feb; 88(1):183-8. PubMed ID: 11293027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction time slowing in adults with HIV: results of a meta-analysis using brinley plots.
    Hardy DJ; Hinkin CH
    Brain Cogn; 2002 Oct; 50(1):25-34. PubMed ID: 12372349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive reserve during neuropsychological performance in HIV intravenous drug users.
    Vázquez-Justo E; Blanco AP; Vergara-Moragues E; Gestoso CG; Pérez-García M
    Appl Neuropsychol Adult; 2014; 21(4):288-96. PubMed ID: 25265310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base rate of a WMS-R malingering index in a sample of non-compensation-seeking men infected with HIV-1.
    Slick DJ; Hinkin CH; van Gorp WG; Satz P
    Appl Neuropsychol; 2001; 8(3):185-9. PubMed ID: 11686655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group.
    Marcotte TD; Heaton RK; Wolfson T; Taylor MJ; Alhassoon O; Arfaa K; Ellis RJ; Grant I
    J Int Neuropsychol Soc; 1999 Nov; 5(7):579-92. PubMed ID: 10645701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of factors not related with HIV infection on neuropsychological performance of HIV-seropositive patients].
    Vázquez-Justo E; Rodríguez-Alvarez M
    Rev Neurol; 2002 Sep 1-15; 35(5):474-80. PubMed ID: 12373683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of previous alcohol abuse on cognitive function in HIV infection.
    Green JE; Saveanu RV; Bornstein RA
    Am J Psychiatry; 2004 Feb; 161(2):249-54. PubMed ID: 14754773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Edinburgh cohort of HIV-positive drug users: the relationship between auditory P3 latency, cognitive function and self-rated mood.
    Egan VG; Chiswick A; Brettle RP; Goodwin GM
    Psychol Med; 1993 Aug; 23(3):613-22. PubMed ID: 8234568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.